Search research articles
Contact Us
Filters
Showing results (251-260 of 262) with videos related to
Page
of 27
Sort By:
Toxicology and Applied Pharmacology
|
June 11, 2024
Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach
Claire Beausoleil, Anne Thébault, Patrik Andersson, et al.
Alternatives to Laboratory Animals : ATLA
|
January 12, 2008
Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63
Michel Bouvier d'Yvoire, Pilar Prieto, Bas J Blaauboer, et al.
Open Research Europe
|
February 11, 2025
A 2024 inventory of test methods relevant to thyroid hormone system disruption for human health and environmental regulatory hazard assessment
Lucia Vergauwen, Lola Bajard, Sabrina Tait, et al.
Ecotoxicology and Environmental Safety
|
August 8, 2021
Dying for change: A roadmap to refine the fish acute toxicity test after 40 years of applying a lethal endpoint
Ioanna Katsiadaki, Tim Ellis, Linda Andersen, et al.
ESMO Open
|
December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
L J Schipper, K G Samsom, P Snaebjornsson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 9, 2020
A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals
Mirjam Luijten, Raffaella Corvi, Jyotigna Mehta, et al.
Science Advances
|
February 11, 2021
Nondestructive, high-resolution, chemically specific 3D nanostructure characterization using phase-sensitive EUV imaging reflectometry
Michael Tanksalvala, Christina L Porter, Yuka Esashi, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo
Sarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Cancer Discovery
|
June 5, 2014
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
Darren A E Cross, Susan E Ashton, Serban Ghiorghiu, et al.
Frontiers in Toxicology
|
July 26, 2023
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens-a PARC project
Marc Audebert, Ann-Sophie Assmann, Amaya Azqueta, et al.
Page
of 27
Search research articles
Search
Showing results (251-260 of 262) with videos related to
Sort By:
Page
of 27
Toxicology and Applied Pharmacology
|
June 11, 2024
Weight of evidence evaluation of the metabolism disrupting effects of triphenyl phosphate using an expert knowledge elicitation approach
Claire Beausoleil, Anne Thébault, Patrik Andersson, et al.
Alternatives to Laboratory Animals : ATLA
|
January 12, 2008
Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63
Michel Bouvier d'Yvoire, Pilar Prieto, Bas J Blaauboer, et al.
Open Research Europe
|
February 11, 2025
A 2024 inventory of test methods relevant to thyroid hormone system disruption for human health and environmental regulatory hazard assessment
Lucia Vergauwen, Lola Bajard, Sabrina Tait, et al.
Ecotoxicology and Environmental Safety
|
August 8, 2021
Dying for change: A roadmap to refine the fish acute toxicity test after 40 years of applying a lethal endpoint
Ioanna Katsiadaki, Tim Ellis, Linda Andersen, et al.
ESMO Open
|
December 4, 2022
Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
L J Schipper, K G Samsom, P Snaebjornsson, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 9, 2020
A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals
Mirjam Luijten, Raffaella Corvi, Jyotigna Mehta, et al.
Science Advances
|
February 11, 2021
Nondestructive, high-resolution, chemically specific 3D nanostructure characterization using phase-sensitive EUV imaging reflectometry
Michael Tanksalvala, Christina L Porter, Yuka Esashi, et al.
Molecular Cancer Therapeutics
|
July 18, 2013
AZD3514: a small molecule that modulates androgen receptor signaling and function in vitro and in vivo
Sarah A Loddick, Sarah J Ross, Andrew G Thomason, et al.
Cancer Discovery
|
June 5, 2014
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer
Darren A E Cross, Susan E Ashton, Serban Ghiorghiu, et al.
Frontiers in Toxicology
|
July 26, 2023
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens-a PARC project
Marc Audebert, Ann-Sophie Assmann, Amaya Azqueta, et al.
Page
of 27